Ab
antiantibody
immunoinflammatory
anticorrelate
tigatuzumab
soravtansine
countercorrelated
conatumumab
-toxa-
idiospecific
pancytokeratin
naptumomab estafenatox
-ab
reagin
antipolyvalent
chromobody
antigenomic
samalizumab
tenatumomab
panitumumab
ozogamicin
vobarilizumab
immunoinflammation
oleclumab
immunoprobe
agglutinin
agonistic monoclonal antibody
guselkumab
autoantibody
pathoantigen
tabalumab
seroblock
-o-
alloantibody
antiserum
ipilimumab
bococizumab
antiidiotypic
serospecific
presentation
immunospecific
figitumumab
drozitumab
antiplasma
-a-
acrixolimab
vepalimomab
volociximab
lucatumumab
antigenic